NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
07/22/2025
Back to search
Official data from USPTO
ERVACCINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ERVACCINE
ST13
US500000097909881Class
5, 42, 44
Filing
97909881
Registration
7666330
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
07/22/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
04/27/2023
Registration date
01/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/28/2025
Last transaction
07/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
LYON CEDEX 08, FR
Examiner
THOMAS,AMY E
Current location
Historical data usage
Holders and representatives
Holders
ERVIMMUNE
E. T. (pessoa física)
Representatives
Pina Campagna CARTER, DELUCA AND FARRELL LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer; therapeutic vaccines; Medical preparationsT-cell therapy preparations for the treatment of cancer; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposesfor the prevention and treatment of cancer; chemical preparations for medical purposesfor the prevention or treatment of cancer; diagnostic preparations for medical purposes; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology
Class 42
Medical research laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncologyimmunotherapystem cell therapyT-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposesnot for medical purposes; research and development in the field of immunotherapy
Class 44
Medical and surgical services in the field of immunotherapy and oncology; medical diagnosis in the field of oncologymedical diagnosis of cancer; medical testing for diagnostic or treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the diagnosis and treatment of persons; genetic testing services for medical purposes
Publications
History of USPTO decisions and trademark events.
21 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/03/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/18/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/29/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/28/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2024
PUBO
PUBLISHED FOR OPPOSITION
12/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/15/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2024
ALIE
ASSIGNED TO LIE
08/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/22/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/25/2024
GNRT
NON-FINAL ACTION E-MAILED
01/25/2024
CNRT
NON-FINAL ACTION WRITTEN
01/25/2024
DOCK
ASSIGNED TO EXAMINER
01/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/25/2023
NWAP
NEW APPLICATION ENTERED
05/01/2023
Continuous trademark protection
Get notified about every new filing that threatens ERVACCINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.